NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $86,000 | +160.6% | 25,000 | 0.0% | 0.00% | +300.0% |
| Q2 2015 | $33,000 | +57.1% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $21,000 | +110.0% | 25,000 | 0.0% | 0.00% | – |
| Q4 2014 | $10,000 | -90.8% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $109,000 | -12.1% | 25,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $124,000 | -8.8% | 25,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $136,000 | -10.5% | 25,000 | 0.0% | 0.01% | -14.3% |
| Q4 2013 | $152,000 | -8.4% | 25,000 | 0.0% | 0.01% | -22.2% |
| Q3 2013 | $166,000 | +30.7% | 25,000 | 0.0% | 0.01% | +28.6% |
| Q2 2013 | $127,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 41,650 | $253,000 | 0.18% |
| Eidelman Virant Capital | 27,796 | $169,000 | 0.07% |
| WMS Partners, LLC | 63,350 | $384,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 62,742 | $381,000 | 0.05% |
| Brown Advisory Securities, LLC | 10,000 | $61,000 | 0.02% |
| CROFT-LEOMINSTER INC | 20,000 | $121,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 15,479 | $94,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $152,000 | 0.01% |
| CANADA PENSION PLAN INVESTMENT BOARD | 120,913 | $734,000 | 0.00% |
| Virtu KCG Holdings LLC | 23,325 | $140,000 | 0.00% |